T1	TimeInfo 0 8	Woche 10
T2	Condition 19 33	HLA-Mismatches
T5	Medication 49 57	Myfortic
T6	Condition 76 84	Diarrhoe
T7	Medication 85 88	Tac
T8	Medication 118 125	Urbason
T9	LabValues 126 130	Krea
T10	HealthState 139 145	stabil
R2	has_State arg1:T9 arg2:T10	
T11	Measure 114 117	8mg
R3	has_Measure arg1:T8 arg2:T11	
T3	Tx_low 0 17	Woche 10 nach NTX
A1	ref_age T3 patient
T12	Measure 97 113	über Zielbereich
R1	has_Measure arg1:T7 arg2:T12	
A2	Risk T3 increase_risk_factor
T13	Temporal 0 18	Woche 10 nach NTX,
A3	Temporal_Element T13 past_present
T4	Measure 35 48	A/B/DR: 1/1/1
R4	has_Measure arg1:T2 arg2:T4	
T14	Measure 62 71	reduziert
R5	has_Measure arg1:T5 arg2:T14	
A4	Risk T5 increase_risk_factor
T15	Temporal 49 84	Myfortic war reduziert bei Diarrhoe
A5	Temporal_Element T15 past
A6	Risk T7 decrease_risk_factor
T16	Temporal 85 113	Tac aktuell über Zielbereich
A7	Temporal_Element T16 present
A8	Risk T8 decrease_risk_factor
T17	Temporal 114 125	8mg Urbason
A9	Temporal_Element T17 present
A10	Risk T9 decrease_symptom
T18	Temporal 126 145	Krea relativ stabil
A11	Temporal_Element T18 past_present
T19	Temporal 19 48	HLA-Mismatches: A/B/DR: 1/1/1
A12	Temporal_Element T19 past_present
